Vaccination perspectives: the Qdenga® dilemma
The introduction of the Qdenga® dengue vaccine presents both opportunities and challenges. Debate regarding efficacy, safety, and potential risks for dengue-naïve individuals continues. With varying international guidelines and evolving evidence, advising travellers requires detailed risk assessment, up-to-date evidence based decisions, and clear communication.
Authors
- Imogen Koopmans
- Rachael Fletcher
- Catherine C Smith
- Philip Veal
- Dipti Patel
- Samia Richards-Zoubir
Institutions
- National Security Agency (US)
- University College London Hospitals NHS Foundation Trust (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- UK Health Security Agency (GB)
- University College London (GB)
Publication Details
- Journal
- Journal of Travel Medicine
- Published
- 2025-03-09
- DOI
- https://doi.org/10.1093/jtm/taaf023
- Citations
- 7
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 13.15